Stock listing
Guizhou Yibai Pharmaceutical Co. Ltd. Class A
Selected listing: 600594 · SSE · CNY · CN
Guizhou Yibai Pharmaceutical Co. Ltd. Class A (Shanghai:600594), Health Technology. Latest release Aug 21, 2026: "Guizhou Yibai Pharmaceutical Co.…

- Ticker
- Shanghai:600594
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Shanghai
- Currency
- CNY
About Guizhou Yibai Pharmaceutical Co. Ltd. Class A
The company operates in the pharmaceutical sector, focusing on the development and production of various medical products. As a publicly traded entity, it is subject to market fluctuations and regulatory oversight in China.
Latest news from Guizhou Yibai Pharmaceutical Co. Ltd. Class A
"Guizhou Yibai Pharmaceutical Co., Ltd."Announcement on Resolutions of the 2nd Meeting of the 9th Board of Directors
August 20, 2026
"Guizhou Yibai Pharmaceutical Co., Ltd."Announcement on the Selection of Products in the Second Round of Follow-Up Centralized Procurement by the National Alliance for Chinese Patent Medicine Procurement
August 3, 2026
"Guizhou Yibai Pharmaceutical Co., Ltd."Announcement on the Receipt of the "Administrative Penalty Notice" from Guizhou Provincial Drug Administration
July 31, 2026
"Guizhou Yibai Pharmaceutical Co., Ltd."Semi-annual Performance Forecast for 2026
July 14, 2026
"Guizhou Yibai Pharmaceutical Co., Ltd."Announcement on Inclusion of the Company's Pharmaceutical Products in the "National Essential Medicines List (2026 Edition)"
July 10, 2026
Research Guizhou Yibai Pharmaceutical Co. Ltd. Class A
Guizhou Yibai Pharmaceutical Co. Ltd. Class A company profile
View the public company page for Guizhou Yibai Pharmaceutical Co. Ltd. Class A on 6ix.
Guizhou Yibai Pharmaceutical Co. Ltd. Class A news
Read company news and market updates connected to Guizhou Yibai Pharmaceutical Co. Ltd. Class A.
Guizhou Yibai Pharmaceutical Co. Ltd. Class A investor events
Find investor webinars, events, and replay context for Guizhou Yibai Pharmaceutical Co. Ltd. Class A.